MannKind : MNKD

All MannKind Articles

305 Articles

Trey Thoelcke | Aug 12, 2015 at 6:31 AM EDT

The 6 Most Shorted Nasdaq Stocks: AMD Rises to the Top

Between the July 15 and July 31 settlement dates, a modest increase in short interest was enough for AMD to…

Chris Lange | Aug 10, 2015 at 9:10 AM EDT

MannKind Cheered Despite Lower Afrezza Shipments

MannKind reported a smaller than expected second-quarter net loss before the markets opened on Monday.

Chris Lange | Jul 27, 2015 at 7:57 AM EDT

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of…

Douglas A. McIntyre | Jul 25, 2015 at 9:33 AM EDT

Ten Most Shorted Stocks On NASDAQ, Apple’s Drops

GallupAll of the top ten most shorted stocks on the NASDAQ had short interests of over 60 million shares, for the…

Chris Lange | Jul 13, 2015 at 7:55 AM EDT

Short Sellers Back Off Big Biotech

24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.

Trey Thoelcke | Jul 13, 2015 at 6:40 AM EDT

The 6 Most Shorted Nasdaq Stocks in June

Between the June 15 and June 30 settlement dates, the short interest increased in all but one of the six…

Chris Lange | Jun 25, 2015 at 7:50 AM EDT

Short Sellers Get More Selective on Big Biotech

The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech…

Trey Thoelcke | Jun 25, 2015 at 6:40 AM EDT

The 6 Most Heavily Shorted Nasdaq Stocks in June

Between the May 15 and May 29 settlement dates, Sirius XM was dethroned as the most heavily shorted stock traded…

Chris Lange | Jun 10, 2015 at 3:21 PM EDT

5 Stocks a Raging Rally Could Not Save

The markets were in a frenzy Wednesday. However, there were a few companies holding back the rally.

Chris Lange | Jun 10, 2015 at 7:55 AM EDT

Short Sellers Lose Some Conviction Against Big Biotech

The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech…

Trey Thoelcke | Jun 10, 2015 at 6:49 AM EDT

The 6 Most Shorted Nasdaq Stocks in May

Between the May 15 and May 29 settlement dates, Mannkind continued its climb up the ranks of the most heavily…

Jon C. Ogg | Jun 9, 2015 at 2:20 PM EDT

Why MannKind Could Be an Endless Tug-of-War Stock

MannKind remains one of the biggest battleground stocks out there in the realm of biotech and emerging pharmacueticals.

Jon C. Ogg | Jun 8, 2015 at 12:15 PM EDT

Events and Presentations Shake Out MannKind Short Sellers

After finally getting FDA clearance for the inhalable insulin Afrezza, and after a very slow start to the diabetes market,…

Jon C. Ogg | May 31, 2015 at 11:45 AM EDT

5 Key Analyst Stock Picks With 50% to 100% Upside (or Even More)

24/7 Wall St. wanted to review some of the most aggressive analyst upgrades and rehashed ratings where analysts were calling…

Chris Lange | May 28, 2015 at 8:25 AM EDT

Short Sellers Get Even More Ambitious Against Biotech Leaders

The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of…

1 … 11 12 13 14 15 … 21

MannKind : MNKD

All MannKind Articles

The 6 Most Shorted Nasdaq Stocks: AMD Rises to the Top

MannKind Cheered Despite Lower Afrezza Shipments

Short Sellers Back Off Major Biotechs

Ten Most Shorted Stocks On NASDAQ, Apple’s Drops

Short Sellers Back Off Big Biotech

The 6 Most Shorted Nasdaq Stocks in June

Short Sellers Get More Selective on Big Biotech

The 6 Most Heavily Shorted Nasdaq Stocks in June

5 Stocks a Raging Rally Could Not Save

Short Sellers Lose Some Conviction Against Big Biotech

The 6 Most Shorted Nasdaq Stocks in May

Why MannKind Could Be an Endless Tug-of-War Stock

Events and Presentations Shake Out MannKind Short Sellers

5 Key Analyst Stock Picks With 50% to 100% Upside (or Even More)

Short Sellers Get Even More Ambitious Against Biotech Leaders

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

MannKind : MNKD

All MannKind Articles

The 6 Most Shorted Nasdaq Stocks: AMD Rises to the Top

MannKind Cheered Despite Lower Afrezza Shipments

Short Sellers Back Off Major Biotechs

Ten Most Shorted Stocks On NASDAQ, Apple’s Drops

Short Sellers Back Off Big Biotech

The 6 Most Shorted Nasdaq Stocks in June

Short Sellers Get More Selective on Big Biotech

The 6 Most Heavily Shorted Nasdaq Stocks in June

5 Stocks a Raging Rally Could Not Save

Short Sellers Lose Some Conviction Against Big Biotech

The 6 Most Shorted Nasdaq Stocks in May

Why MannKind Could Be an Endless Tug-of-War Stock

Events and Presentations Shake Out MannKind Short Sellers

5 Key Analyst Stock Picks With 50% to 100% Upside (or Even More)

Short Sellers Get Even More Ambitious Against Biotech Leaders

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%